NanoViricides, Inc. (NASDAQ:NNVC) | WebDisclosure

Basculer en Français

9478	Companies
185488	Keywords
117867	Articles
99347	Press releases

Home
Companies
NanoViricides, Inc.

PRESS RELEASE

published on 06/20/2024 at 12:30, 1 year 5 months ago

A Novel Broad-Spectrum Antiviral Against Influenza A Viruses, NV-387, Is Effective in Protecting Lungs from Damage in Lethally Infected Animal Model
NanoViricides, Inc. reports positive results of NV-387 in protecting lungs from damage in influenza virus infection. NV-387 treatment showed reduced lung infiltration, cell death, mucus load, and increased survival

NV-387 NanoViricides Inc Antiviral Nanomedicines Lung Protection Influenza Treatment
BRIEF

published on 06/11/2024 at 12:35, 1 year 5 months ago

NV-387 Shows Promising Antiviral Properties with Sustained Blood Concentration

NanoViricides NV-387 Clinical Trials Broad-spectrum Antiviral Flat Blood Concentration
BRIEF

published on 06/11/2024 at 12:35, 1 year 5 months ago

Le NV-387 présente des propriétés antivirales prometteuses avec une concentration sanguine soutenue

NanoViricides NV-387 Essais Cliniques Antiviral À Large Spectre Concentration Sanguine Plate
PRESS RELEASE

published on 06/11/2024 at 12:30, 1 year 5 months ago

Orally Administered NV-387 Results in Ideal Flat Blood Concentration Profile for Sustained Antiviral Effect
NanoViricides, Inc. reports positive results of broad-spectrum antiviral drug NV-387 in animal models, showing sustained antiviral effect with extended flat blood concentration profile upon oral administration

NV-387 Broad-spectrum Antiviral Drug NanoViricides Inc Animal Models Oral Administration
BRIEF

published on 06/04/2024 at 12:35, 1 year 6 months ago

Sustained Blood Concentration Profile of NV-387 Allows Infrequent Dosing

NanoViricides NV-387 Broad-spectrum Antiviral RSV And COVID-19 Treatment Infrequent Dosing
BRIEF

published on 06/04/2024 at 12:35, 1 year 6 months ago

Le profil de concentration sanguine soutenu du NV-387 permet un dosage peu fréquent

NanoViricides NV-387 Antiviral À Large Spectre Traitement Du VRS Et Du COVID-19 Dosage Peu Fréquent
PRESS RELEASE

published on 06/04/2024 at 12:30, 1 year 6 months ago

The Sustained, Slow Declining, Blood Concentration Profile of NV-387 Enables Infrequent Dosing for Strong Antiviral Effect
NanoViricides, Inc. reports positive pharmacokinetic profile of NV-387 in non-human primate model, showcasing sustained blood concentrations enabling less frequent dosing for its broad-spectrum antiviral agent. The unique polymeric design supports potential against RSV, COVID, and influenza

NV-387 NanoViricides Inc. Broad-spectrum Antiviral Agent Pharmacokinetic Profile RSV COVID Influenza
BRIEF

published on 05/29/2024 at 12:35, 1 year 6 months ago

NanoViricides Unveils Revolutionary Broad-Spectrum Antiviral Agent

NV-387 Clinical Trials Antiviral Nanomedicine Broad-spectrum
BRIEF

published on 05/29/2024 at 12:35, 1 year 6 months ago

NanoViricides dévoile un agent antiviral révolutionnaire à large spectre

NV-387 Essais Cliniques Antiviral Nanomédecine À Large Spectre
PRESS RELEASE

published on 05/29/2024 at 12:30, 1 year 6 months ago

A First-In-Class, Broad-Spectrum Antiviral Agent Intending To Revolutionize Treatment of Viral Infections Including RSV, COVID, Influenzas and More
NanoViricides, Inc. elaborates on its groundbreaking host-mimetic, broad-spectrum antiviral technology platform, NV-387, designed to revolutionize viral infection treatment with advanced decoy mechanisms

NV-387 NanoViricides Inc. Broad-spectrum Host-mimetic Technology Antiviral Agent

Accesswire

Published on 12/05/2025 at 16:00, 13 minutes ago

SMX Didn't Change Its Story; The World Finally Connected the Dots
Published on 12/05/2025 at 15:45, 28 minutes ago

Critical Elements announce la clôture d'un placement privé de 7,0 $ million ca par voie de prise ferme
Published on 12/05/2025 at 15:45, 28 minutes ago

Critical Elements Announces Closing of C$7.0 Million Bought Deal Life Private Placement
Published on 12/05/2025 at 15:35, 38 minutes ago

XCF Global Moves to Double SAF Production with New Rise Reno Expansion
Published on 12/05/2025 at 15:25, 48 minutes ago

Usha Resources Provides Corporate Updates

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 16:00, 13 minutes ago

EQS-Adhoc: TIN INN Holding AG implements financing strategy
Published on 12/05/2025 at 16:00, 13 minutes ago

EQS-Adhoc: Amundi Physical Metals plc: Release of the Half-Year Financial Report as of September 30, 2025
Published on 12/05/2025 at 16:00, 13 minutes ago

Amundi Physical Metals plc: Communiqué de Mise à Disposition du Rapport Financier Semestriel au 30 septembre 2025
Published on 12/05/2025 at 16:00, 13 minutes ago

Amundi Physical Metals plc: Release of the Half-Year Financial Report as of September 30, 2025
Published on 12/05/2025 at 15:47, 25 minutes ago

Form 8.3 - The Vanguard Group, Inc.: NCC Group plc

Les Echos

Published on 12/05/2025 at 15:10, 1 hour 2 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 1 hour 2 minutes ago

Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 2 hours 14 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE
Published on 12/05/2025 at 08:45, 7 hours 28 minutes ago

Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 7 hours 28 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry

View all LES ECHOS COMFI WIRE